ROBERT LAGROU: Open Payments
NPI 1629279351 · CLARKSTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$114,180 in 207 payments from 17 companies in 2025. Trend: 2023 $59,004 · 2024 $90,258 · 2025 $114,180
Speaker / faculty: $67,573Honoraria: $32,175Travel & lodging: $9,510Food & beverage: $4,923
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 85 | $76,243 |
| Supernus Pharmaceuticals, Inc. | 48 | $36,282 |
| Axsome Therapeutics, Inc. | 12 | $428 |
| ABBVIE INC. | 10 | $326 |
| E.R. Squibb & Sons, L.L.C. | 13 | $155 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $146 |
| Vanda Pharmaceuticals Inc. | 5 | $115 |
| Otsuka America Pharmaceutical, Inc. | 7 | $110 |
| Alkermes, Inc. | 4 | $104 |
| Teva Pharmaceuticals USA, Inc. | 4 | $89 |
Products named: INVEGA SUSTENNA, Qelbree, SPRAVATO, Auvelity, VRAYLAR, COBENFY, CAPLYTA, REXULTI.
Industry payments across MI — which companies pay providers there.
